Have questions? We’ve got answers.
Frequently asked questions about SAINT®
General
SAINT is an accelerated form of transcranial magnetic stimulation (TMS), but has some key differences.
- Speed: SAINT condenses treatment into only 5 days, versus 6–9 weeks with conventional TMS. On average, participants reached remission in just 2.6 days rather than 3.5 weeks.
- Personalization: SAINT is the only FDA-cleared depression treatment that uses functional MRI (fMRI) brain imaging to identify a personalized target for stimulation to treat major depression.
- Precision: The combination of the fMRI, a personalized target, and neuronavigation enable SAINT to use best-in-class precision targeting.
- Effectiveness: With over 400 patients treated in clinical trials, SAINT relieved symptoms for 85% of participants, with no serious adverse events.
Candidates for SAINT are adults that have been diagnosed with major depressive disorder and medications like antidepressants have not helped.
Please contact a Verified SAINT Provider to meet with a physician regarding eligibility.
At this time, SAINT is only FDA-cleared for the treatment of major depressive disorder (MDD).
SAINT works to gently stimulate a personalized target that is generated from an MRI scan. SAINT modifies activity in brain networks related to depression and restores mood balance.
Patients and caregivers
Insurance coverage for SAINT is currently limited but we are working to expand it.
- Medicare Fee-for-Service (FFS):
Approved for payment at Verified SAINT Provider hospital sites. - Medicare Advantage (MA), Commercial, and Medicaid Plans:
Coverage is determined on a case-by-case basis through the prior authorization process. Your provider can assist in submitting the necessary documentation and requesting approval from your insurer. - Out-of-Pocket:
Self-pay options are available. Pricing and payment plans vary by site, so please contact your preferred treatment provider directly for details.
SAINT treatment is generally well-tolerated. The most commonly reported side effects are mild headache and temporary scalp irritation at the treatment site. Your Verified SAINT Provider will assist you in resolving any discomfort experienced during your treatment.
Please refer to our Provider Locator to see our Verified SAINT Provider locations.
A SAINT treatment will be 5 consecutive treatment days, typically Monday-Friday. There are 10 sessions a day, each session with 10 minutes of active stimulation followed by a 50 minute rest period. The days are 10 hours long, with time to rest/work throughout the day.
Healthcare professionals
The following codes are used for SAINT insurance claims: 0889T, 0890T, 0891T, 0892T
The SAINT neuromodulation system is contraindicated for use in the following situations:
- In patients with non-removable conductive, ferromagnetic, or other magnetic-sensitive metal anywhere in the head or within 30 cm (12″) of the stimulation coil. Examples include cochlear implants, implanted electrodes or stimulators, aneurysm clips or coils, bullet fragments, ocular implants, and stents. Failure to follow this restriction could result in serious injury or death.
- In patients who have an active or inactive implanted device (including device leads), including deep brain stimulators, cochlear implants, cardiac pacemakers, and vagus nerve stimulators. Contraindicated use could result in serious injury or death.
- In patients with increased intracranial pressure or patients with intracardiac lines, intravenous pumps, or dose calculators.
You can refer a patient to one of our Verified SAINT Providers, listed here.
Please fill out our contact form to get in touch with our sales team.
SNT™ is Magnus’ proprietary software platform that uses state-of-the art computer systems for mapping structural and functional human neural networks to power neurostimulation approaches such as SAINT. The SAINT neuromodulation system is a regulated medical device that uses SNT in combination with neurostimulation and neuronavigation hardware to treat neuropsychiatric illnesses such as depression. SNT and the SAINT neuromodulation system form an FDA-cleared treatment for MDD that is available at numerous hospitals and treatment sites across the U.S. Providers who work with Magnus are given access to utilize SNT software services as part of the SAINT neuromodulation system to provide personalized treatments for their patients.
Find SAINT® near you
Feeling better starts with finding the right care. Find a Verified SAINT Provider near you.